Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high-dose cyclophosphamide: A retrospective review of 141 patients

Transfusion

Volumn 46, Issue 2, 2006, Pages 174-179

  Assouline, Sarit ^a   Sylvestre, Marie Pierre ^b   Carriere, Philippe ^b   Shustik, Chaim ^b   Laneuville, Pierre ^b  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; MESNA; METHYLPREDNISOLONE; PREDNISONE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; CARMUSTINE; CBV PROTOCOL; MYELOABLATIVE AGENT;

ADOLESCENT; ADULT; AGED; CANCER CHEMOTHERAPY; CANCER RELAPSE; CELL COUNT; COMPARATIVE STUDY; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; REVIEW; STEM CELL MOBILIZATION; ARTICLE; HODGKIN DISEASE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYELOABLATIVE AGONISTS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES;

EID: 33644849590     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00695.x     Document Type: Review

References (22)

1. Alegre A Tomas JF Martinez-Chamorro C et al. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high dose cyclophosphamide plus GM-CSF vs. G-CSF alone Bone Marrow Transplant 1997 20 211 7
2. Desikan KR Barlogie B Jagannath S et al. Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma J Clin Oncol 1998 6 1547 53
3. Milone G Leotta S Indelicato F et al. G-CSF alone vs. cyclophosphamide plus G-CSF in peripheral blood PBPC mobilization of patients with lymphoma: results depend on degree of previous treatment Bone Marrow Transplant 2003 31 747 54
4. Narayanasami U Kanteli R Morelli J et al. Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation Blood 2001 98 2059 64
5. Melgaard Knudsen L Jensen L Gaarsdal E et al. A comparative study of sequential priming and mobilization of progenitor cells with rh-G-CSF alone or in high dose cyclophosphamide plus rh-G-CSF Bone Marrow Transplant 2000 26 717 22
6. Pavone V Gaudio F Guarini A et al. Mobilization of PBSCs with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in NHL Bone Marrow Transplant 2002 29 285 90
7. 2 for PBSC mobilization in pre-treated lymphoma patients: a matched pair analysis Blood 1996 88 Suppl 1 Abstract 1571
8. Takeyama K Ogura M Morishima Y et al. A dose-dose finding study of glycosylated G-CSF (lenograstim) combined with CHOP therapy for stem cell mobilization in patient with non-Hodgkin's lymphoma Jpn J Clin Oncol 2003 33 78 85
9. Mayer J Koristek Z Pospisil Z et al. Ifosfamide and etoposide based chemotherapy as salvage and mobilization regimens for poor prognosis lymphoma Bone Marrow Transplant 1999 23 413 9
10. Ketterer N Salles G Moullet I et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies Br J Haematol 1998 103 235 42
11. Canales MA Fernandez-Jimenez MC Martin A et al. Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease Haematologica 2001 86 4949 58
12. Moskowitz CH Glassman JR Wuest D et al. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma Clin Cancer Res 1998 311 6
13. Tarella C Castellino C Cherasco C et al. Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at relapse: comparison with patient at diagnosis an impact on clinical outcome Br J Haematol 1997 99 41 6
14. Keeney M Chin-Yee I Weir K et al. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering Cytometry 1998 34 61 70
15. Rothman KJ Greenland S Modern epidemiology. 2nd ed. Philadelphia Lippincott-Raven; 1998. p. 3 87 9
16. Cohen S Lacroix L Blake G et al. High dose etoposide and cyclophosphamide therapy in refractory/relapsed lymphomas - an update of 85 patients [Abstract 849] Blood 1997 90 192a
17. Gribben JG Neuberg D Freedman AS et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma Blood 1993 81 3449 57
18. Sharp JG Kessinger A Mann S et al. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest J Clin Oncol 1996 14 214 9
19. Henry JM Sykes PJ Brisco MJ et al. Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests Br J Haematol 1996 92 614 9
20. Stewart AK Vescio R Schiller G et al. Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial J Clin Oncol 2001 19 3771 9
21. Yuen AR Rosenberg SA Hoppe RT et al. Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease Blood 1997 89 814 22
22. Cortelazzo S Rambaldi A Rossi A et al. Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma Br J Haematol 2001 114 333 41